Држава: Ирска
Језик: Енглески
Извор: HPRA (Health Products Regulatory Authority)
CHLORDIAZEPOXIDE HYDROCHLORIDE
Ranbaxy Ireland Limited
10 Milligram
Capsules Hard
1986-12-17
IRISH MEDICINES BOARD ACTS 1995 AND 2006 MEDICINAL PRODUCTS(CONTROL OF PLACING ON THE MARKET)REGULATIONS,2007 (S.I. NO.540 OF 2007) PA0408/002/001 Case No: 2050207 The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to RANBAXY IRELAND LIMITED SPAFIELD, CORK ROAD, CASHEL, CO. TIPPERARY, IRELAND an authorisation, subject to the provisions of the said Regulations, in respect of the product RIMA 10 CHLORDIAZEPOXIDE 10 MILLIGRAM CAPSULES HARD The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to the general conditions as may be specified in the said Regulations as listed on the reverse of this document. This authorisation, unless previously revoked, shall continue in force from 24/04/2008. Signed on behalf of the Irish Medicines Board this ________________ A person authorised in that behalf by the said Board. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 25/04/2008_ _CRN 2050207_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Rima 10 Chlordiazepoxide Capsules BP 10 mg. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 10mg chlordiazepoxide hydrochloride. Also contains 170mg lactose monohydrate. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Capsules, hard Capsules with black cap and green body, containing a white powder and printed "RIMA 10". 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS 1 Anxiety. 2 In the control of muscle spasm. 3 In the management of alcohol withdrawal. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Anxiety: Treatment should be as short as possible. The patient should Прочитајте комплетан документ